In the control BPH cohort, AZGP1 showed significant low positive correlation with MDH2 (r = 0.491; p = 0.048) and moderate positive correlation with FABP5 (r = 0.560; p = 0.021) (Figure 4A). This evidence concerns the gene FABP5 and benign prostatic hyperplasia.